Proactive Investors - Finance
01 Jun 2026, 11:42 UTC · 2h ago
Memphasys secures first South-East Asian commercialisation agreement for Felix™
Search tags
Proactive Investors - Finance
01 Jun 2026, 11:42 UTC · 2h ago
Search tags
Story key points
3 claims · impact-rated
Memphasys Ltd has signed an exclusive two-year distribution agreement with TMSC Viet Nam for its Felix™ sperm separation system in Vietnam. — Entering a new high-growth geographic market validates the company's global scalability and expands its commercial footprint.
+0.40The partnership is valued at A$530,000 over two years, with A$205,000 expected in Year 1 and A$325,000 in Year 2. — Provides concrete, though modest, revenue projections and confirms a growth trajectory via quarterly cartridge orders.
+0.20Full commercial sales in Vietnam are pending regulatory approval, with registration expected in August 2026. — Creates a short-term dependency on regulatory clearance before the full financial value of the deal can be realized.
-0.10Ticker attribution
Model heads
Continue reading
6 related stories
The company secured its first commercial partnership in South-East Asia with a two-year agreement valued at A$530,000.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
4 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Newsfile Corp
1d ago
